Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) has become the most common liver disorder in Western countries and is increasingly being recognized in developing nations. Fatty liver disease encompasses a spectrum of hepatic pathology, ranging from simple steatosis to non-alcoholic steatohepatitis, cirrho...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Autores principales: Federico, Alessandro, Zulli, Claudio, de Sio, Ilario, Del Prete, Anna, Dallio, Marcello, Masarone, Mario, Loguercio, Carmela
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2014
Materias:
Topic Highlight
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258554/
https://ncbi.nlm.nih.gov/pubmed/25492998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i45.16841
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares